En Es
Categories

Shenzhen YHLO Biotech Co., Ltd.

Shenzhen YHLO Biotech Co., Ltd. (YHLO) is an immunoassay solutions company that specializes in developing, manufacturing and distributing in-vitro diagnostic instruments and reagents with own intellectual properties. Based on the technology platforms of chemiluminescence (CLIA), monotest ELISA, line immunoblot, immunofluorescenc ...
Gold member
Products Covid-19NewsSummary
Close

Covid-19 Shenzhen YHLO Biotech Co., Ltd.

Clinical Laboratory

COVID-19 Antigen Saliva Rapid Test
GLINE-2019-nCoV Antigen Saliva Rapid Test

The GLINE-2019-nCoV Antigen Saliva is a rapid antigen salivary test that detects nucleocapsid protein of the SARS-CoV-2 virus based on colloidal gold immunochromatography assay (CGIA). The assay is more acceptable by users and makes home-testing possible.
More details

COVID-19 Neutralization Antibody Test
iFlash-2019-nCoV Neutralization Antibody Test

The iFlash-2019-nCoV NAb (Neutralization Antibody) assay is a chemiluminescence immunoassay (CLIA) for the qualitative determination of 2019-nCoV Neutralization Antibodies in human serum or plasma. The assay can simulate the in vivo binding of SARS-CoV-2 RBD to ACE2-receptor in human host cells after SARS-CoV-2 infection or vaccination.
More details

SARS-COV-2 Antigen Test
iFlash-2019-nCoV Antigen Test

YHLO iFlash-2019-nCoV Antigen Test applies the chemiluminescent immunosassay (CLIA) for the qualitative detection of SARS-COV-2 antigen in nasal swab or nasopharyngeal swab.
More details

SARS-COV-2 Rapid Antigen Test
UNICELL-2019-nCoV Rapid Antigen Test

YHLO UNICELL-2019-nCoV rapid antigen test utilizes the lateral flow immunofluorescent sandwich assay and provides test result within 15 minutes.
More details

SARS-COV-2 IgM/IgG Rapid Qualitative Test
GLINE-2019-nCoV IgM/IgG Rapid Qualitative Test

YHLO GLINE -2019-nCoV IgM/IgG Rapid Qualitative Test (Colloidal Gold Assay) is a POCT kit for qualitative determination of IgM and IgG antibodies to 2019-nCoV in human whole blood, serum or plasma.
More details

SARS-CoV-2 IgM & IgG CLIA Assays
iFlash 3000 / iFlash 1800 / iModules

YHLO’s IgG and IgM combined detection is a good supplementary diagnostic tool to PCR, which can identify who are immune to COVID-19 after infection in mass population and its titer change can be used to monitor treatment of COVID-19 patients. Together with iFlash fully automation system, manual work and aerosol contamination risk can be reduced. The assays are CE marked, FDA EUA application accepted and legal export qualification obtained.
More details
Close

News of Shenzhen YHLO Biotech Co., Ltd.

YHLO Helps China’s Top Ranking Hospital PUMCH to Upgrade from Traditional ELISA to CLIA Technology

06 Jan 2021
YHLO Helps China’s Top Ranking Hospital PUMCH to Upgrade from Traditional ELISA to CLIA Technology
Shenzhen YHLO Biotech Co., Ltd. (Shenzhen, China) has helped China’s top ranking hospital, Peking Union Medical College Hospital (PUMCH; Beijing, China), to successfully upgrade its laboratory from the traditional ELISA (enzyme-linked immunoassay) technology to CLIA (chemiluminescence immunoassay) technology.
Read More
Close

About Shenzhen YHLO Biotech Co., Ltd.

Shenzhen YHLO Biotech Co., Ltd. (YHLO) is an immunoassay solutions company that specializes in developing, manufacturing and distributing in-vitro diagnostic instruments and reagents with own intellectual properties. Based on the technology platforms of chemiluminescence (CLIA), monotest ELISA, line immunoblot, immunofluorescence, YHLO has developed hundreds of test items on autoimmunity, reproductive health, diabetes, infection and routine immunochemistry. YHLO is one of the very few suppliers in China for autoimmune instruments and reagents, and has launched China`s first monotest ELISA analyzer – UNION, China`s first ESR analyzer with direct EDTA tube testing – VISION, China`s first high-speed Chemiluminescence System - iFlash 3000 CLIA System (300 T/H), and China`s first autoimmune assays in CLIA, LIA and ELISA platforms. YHLO has also launched Anti-Müllerian Hormone (AMH) dedicated to ELISA and CLIA systems, as well as the world`s first CLIA assays for Inhibin B, Adiponectin, ZnT8A, RA33, etc. In 2020, YHLO launched CLIA assays of SARS-CoV-2 IgM and IgG to aid the diagnosis of COVID-19.
FaceBook Twitter Google+ Linked in
SARS-COV-2 Antigen Test

SARS-COV-2 Antigen Test

Model: iFlash-2019-nCoV Antigen Test
Request Information

Description:

YHLO iFlash-2019-nCoV Antigen Test applies the chemiluminescent immunosassay (CLIA) for the qualitative detection of SARS-COV-2 antigen in nasal swab or nasopharyngeal swab.

Features

Features

● Reliable Result: High Sensitivity and Specificity
● High Throughput: Up to 300 T/h
● Full Automation: Automated workflow reduces manual operation and avoids cross-infection to make the operators safety.
● Reputation: iFlash CLIA solutions have been applied and evaluated by more than one hundred of published academic studies. Request Information

Send A Message To This Supplier

* Required Information
* Email
To
Shenzhen YHLO Biotech Co., Ltd. (SARS-COV-2 Antigen Test)
* Message

Copyright © 2000-2021 TradeMed.com. All rights reserved. | Terms And Conditions